Company Profile

Schrödinger develops computational software for discovering and designing molecules for drug development and materials science. Its platform combines physics-based molecular simulations, machine learning, and AI to predict molecular properties, screen compounds, optimize drug candidates, and study biological interactions. The company also provides tools for antibody design, protein modeling, materials research, molecular dynamics, and virtual screening.